Treatment of leiomyomatosis peritonealis disseminata with goserelin acetate: A case report and review of the literature
Sign Up to like & getrecommendations! Published in 2021 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v9.i19.5217
Abstract: BACKGROUND Leiomyomatosis peritonealis disseminata (LPD) is a rare condition characterized by multiple pelvic and abdominal nodules, which are composed of smooth-muscle cells. To date, no more than 200 cases have been reported. The diagnosis of… read more here.
Keywords: goserelin; goserelin acetate; peritonealis disseminata; leiomyomatosis peritonealis ... See more keywords
A review of clinical evidence to assess differences in efficacy and safety of luteinizing hormone–releasing hormone (LHRH) agonist (goserelin) and LHRH antagonist (degarelix)
Sign Up to like & getrecommendations! Published in 2022 at "Indian Journal of Cancer"
DOI: 10.4103/ijc.ijc_1415_20
Abstract: Luteinizing hormone–releasing hormone agonist (LHRH-A), goserelin, and antagonist, degarelix, are both indicated for the treatment of advanced prostate cancer (PCa); however, large comparative trials evaluating their efficacy and safety are lacking. In this review, we… read more here.
Keywords: goserelin; luteinizing hormone; degarelix; evidence ... See more keywords
Gonadotropin-releasing hormone agonists in prostate cancer: A comparative review of efficacy and safety
Sign Up to like & getrecommendations! Published in 2022 at "Indian Journal of Cancer"
DOI: 10.4103/ijc.ijc_65_21
Abstract: Androgen deprivation therapy (ADT) using gonadotropin-releasing hormone agonist (s) (GnRH-A) remains the backbone of advanced prostate cancer treatment. In this review, we assessed the efficacy, safety, and convenience of administration of various GnRH-A. All GnRH-A… read more here.
Keywords: goserelin; cancer; prostate cancer; rate ... See more keywords